Canada Life’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $458K | Hold |
10,491
| – | – | ﹤0.01% | 1625 |
|
|
2025
Q1 | $288K | Hold |
10,491
| – | – | ﹤0.01% | 1691 |
|
|
2024
Q4 | $422K | Hold |
10,491
| – | – | ﹤0.01% | 1669 |
|
|
2024
Q3 | $497K | Hold |
10,491
| – | – | ﹤0.01% | 1671 |
|
|
2024
Q2 | $313K | Buy |
10,491
+6,560
| +167% | +$196K | ﹤0.01% | 1766 |
|
|
2024
Q1 | $158K | Hold |
3,931
| – | – | ﹤0.01% | 1865 |
|
|
2023
Q4 | $99K | Buy |
3,931
+2,287
| +139% | +$57.6K | ﹤0.01% | 1950 |
|
|
2023
Q3 | $23K | Hold |
1,644
| – | – | ﹤0.01% | 2108 |
|
|
2023
Q2 | $38K | Hold |
1,644
| – | – | ﹤0.01% | 2035 |
|
|
2023
Q1 | $49K | Hold |
1,644
| – | – | ﹤0.01% | 2071 |
|
|
2022
Q4 | $41K | Hold |
1,644
| – | – | ﹤0.01% | 2114 |
|
|
2022
Q3 | $36K | Hold |
1,644
| – | – | ﹤0.01% | 2160 |
|
|
2022
Q2 | $32K | Hold |
1,644
| – | – | ﹤0.01% | 2159 |
|
|
2022
Q1 | $74K | Buy |
1,644
+392
| +31% | +$17.6K | ﹤0.01% | 2074 |
|
|
2021
Q4 | $79K | Buy |
1,252
+507
| +68% | +$32K | ﹤0.01% | 2063 |
|
|
2021
Q3 | $44K | Hold |
745
| – | – | ﹤0.01% | 2266 |
|
|
2021
Q2 | $36K | Hold |
745
| – | – | ﹤0.01% | 2357 |
|
|
2021
Q1 | $29K | Hold |
745
| – | – | ﹤0.01% | 2448 |
|
|
2020
Q4 | $46K | Buy |
+745
| New | +$46K | ﹤0.01% | 2307 |
|